A comprehensive view of Conference on Retroviruses and Opportunistic Infections. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva cabotegravir + rilpivirine compared to daily oral therapy in individuals with HIV who have adherence challenges
Published: March 06, 2024 by GSK Group (GlaxoSmithKline)
Gilead to present new data on HIV, COVID-19 and viral hepatitis treatments at the 31st Conference on Retroviruses and Opportunistic Infections; the analyses from nearly 80 studies include research on Biktarvy, Veklury, and Hepcludex
Published: February 26, 2024 by Business Wire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count